Evidence map›Paper›PMID 37900701›Full record

ArticleCurrent bioactive compounds2023

Syeda Andleeb Zehra, Prapanna Bhattarai, Jian Zhang, Yin Liu, Zahida Parveen, Muhammad Sajid, Lin Zhu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current bioactive compounds, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Evaluating the Antioxidant and Antidiabetic Properties ofMolecules (Basel, Switzerland) · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Syeda Andleeb ZehraDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, 78363, USA.
Prapanna BhattaraiDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, 78363, USA.
Jian ZhangDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, 78363, USA.
Yin LiuDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, 78363, USA.
Zahida ParveenDepartment of Biochemistry, Abdul Wali Khan University, Mardan, 23200, Pakistan.
Muhammad SajidDepartment of Biochemistry, Faculty of Health Sciences, Hazara University, Mansehra, 21300, Pakistan.
Lin ZhuDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, 78363, USA.
Hazara University · PKAbdul Wali Khan University Mardan · PK

Funding

Improving tumor specificity and overcoming drug resistance of proteasome inhibitors by a dual-targeted drug delivery systemR15CA213103 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZHU, LIN · 2018 to 2018
$444k
NCI NIH HHS R15 CA213103
6 · The paper itself

Abstract

Background: Methods: Three extracts of Results: We found that the Conclusion: Our findings suggested that the

Indexed as

advanced glycation end productsGC-MSglucose transporterprotein tyrosine phosphatase 1BSolidago virgaureaα-glucosidase

Identifiers

PMID37900701
PMCPMC10601339
OpenAlexW4282961153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.